Literature DB >> 3902185

Coexistence of idiopathic Parkinson's disease and Creutzfeldt-Jakob disease.

C Ezrin-Waters, L Resch, A E Lang.   

Abstract

The association of idiopathic Parkinson's disease and Creutzfeldt-Jakob disease has not been reported previously. We describe the clinical findings in a patient with both disorders, confirmed at autopsy. The differential diagnosis of parkinsonism with cognitive and psychiatric disturbances is reviewed with emphasis on conditions which may complicate the course of idiopathic Parkinson's disease. The etiological implications of this combination are considered.

Entities:  

Mesh：

Year:  1985        PMID： 3902185     DOI： 10.1017/s0317167100047156

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN： 0317-1671            Impact factor:   2.104


  4 in total

1.  Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.

Authors:  Elizaveta Katorcha; Natallia Makarava; Young Jin Lee; Iris Lindberg; Mervyn J Monteiro; Gabor G Kovacs; Ilia V Baskakov
Journal:  PLoS Pathog       Date:  2017-08-10       Impact factor: 6.823

2.  Parkinson's disease with a typical clinical course of 17 years overlapped by Creutzfeldt-Jakob disease: an autopsy case report.

Authors:  Shin-Ichiro Kubo; Tomoyasu Matsubara; Takeshi Taguchi; Renpei Sengoku; Atsuko Takeuchi; Yuko Saito
Journal:  BMC Neurol       Date:  2021-12-10       Impact factor: 2.474

3.  Spatiotemporal modulations in heterotypic condensates of prion and α-synuclein control phase transitions and amyloid conversion.

Authors:  Aishwarya Agarwal; Lisha Arora; Sandeep K Rai; Anamika Avni; Samrat Mukhopadhyay
Journal:  Nat Commun       Date:  2022-03-03       Impact factor: 14.919

4.  α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication.

Authors:  Suzana Aulić; Lara Masperone; Joanna Narkiewicz; Elisa Isopi; Edoardo Bistaffa; Elena Ambrosetti; Beatrice Pastore; Elena De Cecco; Denis Scaini; Paola Zago; Fabio Moda; Fabrizio Tagliavini; Giuseppe Legname
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.